In the tumor microenvironment, CCL22 induces Treg infiltration, which further inhibits the function of CD8T cells and NK cells, forming an immunosuppressive environment and ultimately leading to tumor growth (Korbecki et al., 2020). This evidence concerns the gene CCL22 and neoplasm.